Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan;37(1):105-112.
doi: 10.5534/wjmh.180051.

Effect of Korean Herbal Formula (Modified Ojayeonjonghwan) on Androgen Receptor Expression in an Aging Rat Model of Late Onset Hypogonadism

Sae Woong Choi  1 , Seung Hwan Jeon  2 , Eun Bi Kwon  2 , Guan Qun Zhu  2 , Kyu Won Lee  2 , Jin Bong Choi  3 , Hyun Cheol Jeong  4 , Kang Sup Kim  5 , Sang Rak Bae  6 , Woong Jin Bae  1   7 , Su Jin Kim  8 , Hyuk Jin Cho  2 , U Syn Ha  2 , Sung Hoo Hong  2 , Sung Yeoun Hwang  9 , Sae Woong Kim  1   10
Affiliations

Effect of Korean Herbal Formula (Modified Ojayeonjonghwan) on Androgen Receptor Expression in an Aging Rat Model of Late Onset Hypogonadism

Sae Woong Choi et al. World J Mens Health. 2019 Jan.

Abstract

Purpose: Testosterone replacement therapy is an effective treatment for late-onset hypogonadism (LOH) despite a few contraindications and side-effects. The aim of this study was to determine whether modified Ojayeonjonghwan (KH-204, Korean herbal formula) improved LOH. KH-204 is a strong antioxidant herbal formula. We evaluated the effect of Korean herbal prescription on androgen receptor (AR) expression in an aged rat model of LOH.

Materials and methods: Eighteen-month-old rats were used as aged LOH rat models. Eighteen Sprague-Dawley rats were randomly divided into three equal groups of six animals each and treated with one of the following: 1) normal control group (oral administration with distilled water, n=6), 2) KH-204 200 group (oral administration with 200 mg/kg of KH-204, n=6), and 3) KH-204 400 group (oral administration with 400 mg/kg of KH-204, n=6). After four weeks of treatment (once daily, distilled water or KH-204), serum testosterone levels, changes in testicular and epididymal weight, Western blotting analysis of AR expression and measurement of oxidative stress were examined.

Results: Treatment with the herbal formulation KH-204 200 mg/kg and 400 mg/kg (1) increased the weights of testis and epididymis; (2) increased the level of serum testosterone; (3) increased the level of superoxide dismutase and reduced the level of 8-hydroxy-20-deoxyguanosine; and (4) upregulated AR expression in testicular tissue.

Conclusions: KH-204 might be an effective alternative for LOH. It improves antioxidant mechanisms and increases testicular AR expression without side-effects.

Keywords: Hypogonadism; Phytotherapy; Receptors, androgen; Testosterone.

PubMed Disclaimer

Conflict of interest statement

The authors have no potential conflicts of interest to disclose.

Figures

Fig. 1
Fig. 1. Effects of KH-204 on serum testosterone levels (n=6/group). All values represent mean±standard deviation, *p<0.05 compared with control group.
Fig. 2
Fig. 2. Comparison of expression levels of oxidative stress markers as reflected by superoxide dismutase (SOD) (A) and 8-hydroxy-2-deoxyguanosine (8-OHdG) (B). All values are mean±standard deviation, *p<0.005 compared with control group.
Fig. 3
Fig. 3. Western blots for expression of androgen receptor (AR) of KH-204 and control groups in male Sprague-Dawley rat testis and prostate tissue. In this figure, panel A and B show testis, whereas panel C and D present prostate data. Data are expressed as means. *Statistical significance in comparison with control group.
See this image and copyright information in PMC

References

    1. Lunenfeld B, Mskhalaya G, Kalinchenko S, Tishova Y. Recommendations on the diagnosis, treatment and monitoring of late-onset hypogonadism in men: a suggested update. Aging Male. 2013;16:143–150. - PubMed
    1. Dean JD, McMahon CG, Guay AT, Morgentaler A, Althof SE, Becher EF, et al. The International Society for Sexual Medicine's process of care for the assessment and management of testosterone deficiency in adult men. J Sex Med. 2015;12:1660–1686. - PubMed
    1. Gray A, Feldman HA, McKinlay JB, Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts male aging study. J Clin Endocrinol Metab. 1991;73:1016–1025. - PubMed
    1. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab. 2002;87:589–598. - PubMed
    1. Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363:123–135. - PubMed